Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.72 +1.12%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
PKE, LNN, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
- Lucid reports Q2 output, names new CFO and five other leaders
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
